COMPARISON OF TRANSDERMAL AND SUBCUTANEOUS TERIPARATIDE EFFECTS ON MARKERS OF BONE TURNOVER AND SAFETY IN POSTMENOPAUSAL WOMEN

被引：0
|
作者：
Kenan, Y. [1 ]
Kochba, E. [1 ]
Shahar, M. [1 ]
Gadasi, H. [1 ]
Levin, G. [1 ]
Foldes, A. J. [2 ]
Ish-Shalom, S. [3 ]
Matsumoto, T. [4 ]
Lindsay, R. [5 ]
Christiansen, C. [7 ]
Neer, R. [6 ]
机构：
[1] TransPharma Med Ltd, Lod, Israel
[2] Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel
[3] Rambam Hlth Care Ctr, Metabol Bone Dis Unit, Haifa, Israel
[4] Univ Tokushima, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Tokushima 770, Japan
[5] Helen Hayes Hosp, W Haverstraw, NY USA
[6] Massachusetts Gen Hosp, Boston, MA USA
[7] Nord Biosci, Herlev, Denmark
来源：
OSTEOPOROSIS INTERNATIONAL | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：178 / 178
页数：1
相关论文
共 50 条
  • [21] Effects of vitamin E on bone turnover markers among US postmenopausal women
    Hamidi, Maryam S.
    Corey, Paul N.
    Cheung, Angela M.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (06) : 1368 - 1380
  • [22] Effects and safety of Pueraria mirifica on lipid profiles and biochemical markers of bone turnover rates in healthy postmenopausal women
    Manonai, Jittina
    Chittacharoen, Apichart
    Udomsubpayakul, Umaporn
    Theppisai, Hathai
    Theppisai, Urusa
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (03): : 530 - 535
  • [23] Effects of raloxifene and alendronate on bone mineral density and bone turnover markers in postmenopausal women with osteoporosis
    Johnell, O
    Lu, Y
    Seeman, E
    Reginster, J
    Scheele, W
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S184 - S184
  • [24] Bone turnover markers do not identify bone status in postmenopausal women
    Muñoz-Torres, M
    Mezquita-Raya, P
    López-Rodríguez, F
    Escobar-Jiménez, F
    BONE, 2001, 28 (05) : S178 - S178
  • [25] Comparison of the effects of alendronate and risedronate on bone mineral density and bone turnover markers in postmenopausal osteoporosis
    Mengu Sarioglu
    Cigdem Tuzun
    Zeliha Unlu
    Canan Tikiz
    Fatma Taneli
    B. Sami. Uyanik
    Rheumatology International, 2006, 26 : 195 - 200
  • [26] Comparison of the effects of alendronate and risedronate on bone mineral density and bone turnover markers in postmenopausal osteoporosis
    Sarioglu, M
    Tuzun, C
    Unlu, Z
    Tikiz, C
    Taneli, F
    Uyanik, BS
    RHEUMATOLOGY INTERNATIONAL, 2006, 26 (03) : 195 - 200
  • [27] Effects of Denosumab on Bone Turnover Markers in Postmenopausal Osteoporosis
    Eastell, Richard
    Christiansen, Claus
    Grauer, Andreas
    Kutilek, Stepan
    Libanati, Cesar
    McClung, Michael R.
    Reid, Ian R.
    Resch, Heinrich
    Siris, Ethel
    Uebelhart, Daniel
    Wang, Andrea
    Weryha, Georges
    Cummings, Steve R.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (03) : 530 - 537
  • [28] The gut microbiome is associated with bone turnover markers in postmenopausal women
    Chen, Lin
    Yan, Shuai
    Yang, Ming
    Yu, Fudong
    Wang, Jingjing
    Wang, Xiaoxin
    Xu, Huanbai
    Shi, Jianxia
    Pan, Ling
    Zeng, Yuexi
    Li, Siyu
    Li, Li
    You, Li
    Peng, Yongde
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (11): : 12601 - 12613
  • [29] Endotoxin and bone turnover markers in postmenopausal women with and without osteoporosis
    Aziz, Ibrahim
    Yakout, Sobhy M.
    Aljohani, Naji
    Al-Saleh, Yousef
    Al-Attas, Omar S.
    Alokail, Majed S.
    Amer, Osama E.
    Sheshah, Eman
    McTernan, Philip G.
    Al-Daghri, Nasser M.
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (10): : 10682 - 10687
  • [30] Effects of ospemifene, a novel SERM, on biochemical markers of bone turnover in healthy postmenopausal women
    Komi, J
    Heikkinen, J
    Rutanen, EM
    Halonen, K
    Lammintausta, R
    Yikorkala, O
    GYNECOLOGICAL ENDOCRINOLOGY, 2004, 18 (03) : 152 - 158
12345